Developer docs
API playgroundTry for free, no card

Search company profiles

Ruakura Technologies

Full company profile

uuid0007t31

Namestring
Ruakura Technologies
Legal namestring
Ruakura Technologies Ltd
Websiteurl
ruatech.co.nz
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Ruakura Technologies Ltd is a New Zealand biotechnology startup founded in 2020 and headquartered at the Ruakura Research Centre in Hamilton. The company is developing an immune milk platform that uses designed antigens to immunize dairy cows, generating pathogen-specific antibodies that are transferred into milk. This immune milk is processed into powder and intended to be formulated into oral consumer products such as beverages and chewables. The company's initial product focus is protection against SARS-CoV-2, positioned as a complement to conventional vaccines rather than a replacement.

Short descriptiontext

Ruakura Technologies is a New Zealand biotechnology startup developing an immune milk platform that uses dairy cow antibodies, formulated into beverages and chewables, to provide COVID-19 protection for individual consumers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHamilton, New Zealand
HQ citystring
Hamilton
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immune milk technology, biotechnology consumer products, pathogen protection products, antibody-based therapeutics, dairy-derived bioactives
Industry2 codes
PRIMARYAFAHAIAE
Functional & Fortified Dairy Drinks (Vitamins/Minerals, Lactose-Free, A2, Added Fiber)
Agriculture & Food Production/Dairy Processing/Dairy-Based Beverages & Drinkable Dairy (Flavored Milk, Lassi, Protein Shakes)
SECONDARYAFAKAKAH
Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt)
NAICS code3 codes
  • Dairy Product Manufacturing3115
  • Dairy Product (except Frozen) Manufacturing31151
  • Fluid Milk Manufacturing311511
SIC code2 codes
  • Dairy Products2020
  • Food And Kindred Products2000
Product category
Biotechnology Consumer Products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Immune Milk Consumer Products
TypeOne Time License
Description

Products under development - immune milk powder formulated into consumer products (beverages and chewables) for discretionary consumer use. Revenue model not yet disclosed as company is pre-revenue with products in development stage.

ruatech.co.nz
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Supply Chain
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Ruakura Technologies is developing an immune milk platform that uses designed antigens for targeted human pathogens to immunize dairy cows, generating pathogen-specific antibodies in their milk. The resulting immune milk powder is being formulated into consumer products (beverages and chewables) for oral consumption, with the initial focus on providing protective effects against SARS-CoV-2/COVID-19.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Ruakura Technologies operates an immune milk platform as its core technology, which generates specific antibodies in dairy cows through targeted antigen immunization. The immune milk is processed into immune milk powder, which serves as the raw material for formulating consumer products. The company's initial product portfolio focuses on COVID-19 protective consumer products for oral consumption (beverages or chewables), with the platform designed to be adaptable to other viral and microbial pathogens beyond SARS-CoV-2.

Product and service1 record
1Immune Milk Platform
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Australian-listed biotech commercialising hyperimmune bovine colostrum products (e.g., Travelan, Protectyn) targeting gut and respiratory pathogens. Direct peer using dairy cows to generate pathogen-specific antibodies for human consumer/therapeutic products.

TypeDirect peer
Description

US-based company commercialising bovine colostrum-based immune products across consumer and paediatric nutrition. Closely comparable dairy-cow antibody platform with established distribution and commercial revenue.

TypeDirect peer
Description

Clinical-stage biotech using genetically engineered cattle to produce fully human polyclonal antibodies against infectious diseases. Most direct scientific analogue: same core concept (cows as antibody bioreactors for human pathogens) but at clinical stage.

4AgriLabs / Huvepharma (colostrum lines)
TypeBroad incumbent
Description

Large animal-health and nutrition companies with established bovine colostrum and immune-milk product lines for human and veterinary markets. Comparable dairy-antibody production model at industrial scale.

5Symbiotics / APS Biogroup
TypeDirect peer
Description

Producer of hyperimmune colostrum and immune egg products targeted at human immune health, including COVID-era products. Directly comparable hyperimmune dairy platform addressing similar consumer immune-protection use cases.

TypeBroad incumbent
Description

Large global dairy ingredients and bioactive-protein manufacturer with capability in functional dairy beverages. Comparable as a scaled dairy-based functional beverage manufacturer and potential partner/competitor in immune-support drinks.

TypeRegional player
Description

New Zealand-based specialty dairy processor with R&D capability in functional and nutritional milk products. Regional peer with infrastructure, NZ presence, and capability to manufacture or partner on immune-milk consumer products.

8BioGaia
TypeEmerging player
Description

Swedish probiotics and immune-health consumer health company with established retail distribution for discretionary immune-support products. Comparable as a science-led, small-cap consumer immune-health brand rather than in core mechanism.

TypeBroad incumbent
Description

New Zealand-headquartered global dairy cooperative with major R&D investment in functional dairy ingredients and bioactive proteins. Comparable as NZ-based, large-scale dairy processor with capacity to license or partner on novel milk bioactives.

TypeOthers
Description

New Zealand government innovation agency that has already funded RuaTech. Not a commercial peer but a relevant ecosystem participant that signals NZ R&D infrastructure backing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ruakura Technologies

Biotechnology Consumer Productsruatech.co.nz

Ruakura Technologies is a New Zealand biotechnology startup developing an immune milk platform that uses dairy cow antibodies, formulated into beverages and chewables, to provide COVID-19 protection for individual consumers.

What Ruakura Technologies does

Ruakura Technologies Ltd is a New Zealand biotechnology startup founded in 2020 and headquartered at the Ruakura Research Centre in Hamilton. The company is developing an immune milk platform that uses designed antigens to immunize dairy cows, generating pathogen-specific antibodies that are transferred into milk. This immune milk is processed into powder and intended to be formulated into oral consumer products such as beverages and chewables. The company's initial product focus is protection against SARS-CoV-2, positioned as a complement to conventional vaccines rather than a replacement.

Ruakura Technologies firmographics

Firmographics
Name
Ruakura Technologies
Legal name
Ruakura Technologies Ltd
Website
https://ruatech.co.nz
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Ruakura Technologies is a New Zealand biotechnology startup developing an immune milk platform that uses dairy cow antibodies, formulated into beverages and chewables, to provide COVID-19 protection for individual consumers.
Ownership category
akta.pro rank

Ruakura Technologies industry classification

Industry
Product category
Biotechnology Consumer Products
NAICS
Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151), Fluid Milk Manufacturing (311511)
SIC
Dairy Products (2020), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAHAIAE
Functional & Fortified Dairy Drinks (Vitamins/Minerals, Lactose-Free, A2, Added Fiber)
Agriculture & Food Production/Dairy Processing/Dairy-Based Beverages & Drinkable Dairy (Flavored Milk, Lassi, Protein Shakes)
SECONDARYAFAKAKAH
Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt)

Keywords

  • Immune milk technology
  • Biotechnology consumer products
  • Pathogen protection products
  • Antibody-based therapeutics
  • Dairy-derived bioactives

Where Ruakura Technologies is headquartered

Location

Headquarters

HQ city
Hamilton
HQ country
New Zealand
HQ region
Oceania

Offices1 record

Markets served

Ruakura Technologies business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain

Revenue model

  1. Immune Milk Consumer Products: Products under development - immune milk powder formulated into consumer products (beverages and chewables) for discretionary consumer use. Revenue model not yet disclosed as company is pre-revenue with products in development stage.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Ruakura Technologies product offering

Product offering

Core offering

Ruakura Technologies is developing an immune milk platform that uses designed antigens for targeted human pathogens to immunize dairy cows, generating pathogen-specific antibodies in their milk. The resulting immune milk powder is being formulated into consumer products (beverages and chewables) for oral consumption, with the initial focus on providing protective effects against SARS-CoV-2/COVID-19.

Product overview

Ruakura Technologies operates an immune milk platform as its core technology, which generates specific antibodies in dairy cows through targeted antigen immunization. The immune milk is processed into immune milk powder, which serves as the raw material for formulating consumer products. The company's initial product portfolio focuses on COVID-19 protective consumer products for oral consumption (beverages or chewables), with the platform designed to be adaptable to other viral and microbial pathogens beyond SARS-CoV-2.

Differentiator

Problem solved

Functional benefit

Products and services

  • Immune Milk Platform

Companies that use Ruakura Technologies

Customer profile

Segments1 record

Ideal customer profiles1 record

Ruakura Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Ruakura Technologies partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Ruakura Technologies competitors and assessment

Company assessment

Direct peers

  • Immuron: Australian-listed biotech commercialising hyperimmune bovine colostrum products (e.g., Travelan, Protectyn) targeting gut and respiratory pathogens. Direct peer using dairy cows to generate pathogen-specific antibodies for human consumer/therapeutic products.
  • PanTheryx: US-based company commercialising bovine colostrum-based immune products across consumer and paediatric nutrition. Closely comparable dairy-cow antibody platform with established distribution and commercial revenue.
  • SAb Biotherapeutics: Clinical-stage biotech using genetically engineered cattle to produce fully human polyclonal antibodies against infectious diseases. Most direct scientific analogue: same core concept (cows as antibody bioreactors for human pathogens) but at clinical stage.
  • Symbiotics / APS Biogroup: Producer of hyperimmune colostrum and immune egg products targeted at human immune health, including COVID-era products. Directly comparable hyperimmune dairy platform addressing similar consumer immune-protection use cases.

Broad incumbents

  • AgriLabs / Huvepharma (colostrum lines): Large animal-health and nutrition companies with established bovine colostrum and immune-milk product lines for human and veterinary markets. Comparable dairy-antibody production model at industrial scale.
  • Glanbia Nutritionals: Large global dairy ingredients and bioactive-protein manufacturer with capability in functional dairy beverages. Comparable as a scaled dairy-based functional beverage manufacturer and potential partner/competitor in immune-support drinks.
  • Fonterra (ingredients and ventures): New Zealand-headquartered global dairy cooperative with major R&D investment in functional dairy ingredients and bioactive proteins. Comparable as NZ-based, large-scale dairy processor with capacity to license or partner on novel milk bioactives.

Regional players

  • Synlait Milk: New Zealand-based specialty dairy processor with R&D capability in functional and nutritional milk products. Regional peer with infrastructure, NZ presence, and capability to manufacture or partner on immune-milk consumer products.

Emerging players

  • BioGaia: Swedish probiotics and immune-health consumer health company with established retail distribution for discretionary immune-support products. Comparable as a science-led, small-cap consumer immune-health brand rather than in core mechanism.

Others

  • Callaghan Innovation: New Zealand government innovation agency that has already funded RuaTech. Not a commercial peer but a relevant ecosystem participant that signals NZ R&D infrastructure backing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks7 records

Key highlights6 records

Customer concentration

Ruakura Technologies social profiles

Digital presence

Ruakura Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ruakura Technologies leadership team

Management profile

Number of profiles

Profiles6 records

Ruakura Technologies funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ruakura Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ruakura Technologies

What does Ruakura Technologies do?

Ruakura Technologies is developing an immune milk platform that uses designed antigens for targeted human pathogens to immunize dairy cows, generating pathogen-specific antibodies in their milk. The resulting immune milk powder is being formulated into consumer products (beverages and chewables) for oral consumption, with the initial focus on providing protective effects against SARS-CoV-2/COVID-19.

Is Ruakura Technologies a public or private company?

Ruakura Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Ruakura Technologies founded?

Ruakura Technologies was founded in 2020. It employs 1 to 10 people.

Where is Ruakura Technologies based?

Ruakura Technologies is headquartered in Hamilton, New Zealand, in the Oceania region.

How does Ruakura Technologies make money?

One revenue line is on record: immune Milk Consumer Products.

Who are Ruakura Technologies's main competitors?

Direct peers on record are Immuron, PanTheryx, SAb Biotherapeutics and Symbiotics / APS Biogroup. Broad incumbents are AgriLabs / Huvepharma (colostrum lines), Glanbia Nutritionals and Fonterra (ingredients and ventures). Synlait Milk is listed as a regional player. BioGaia is listed as an emerging player. Callaghan Innovation is listed as an others.

Does Ruakura Technologies have an API?

No public API is recorded for Ruakura Technologies.

What industry is Ruakura Technologies in?

Ruakura Technologies's product category is Biotechnology Consumer Products. Its primary akta.pro industry code is AFAHAIAE, Functional & Fortified Dairy Drinks (Vitamins/Minerals, Lactose-Free, A2, Added Fiber), with a secondary code of AFAKAKAH, Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt). Its NAICS code is 3115 and its SIC code is 2020.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales